{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:07:43Z","timestamp":1793693263483,"version":"4.5.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>During caesarean delivery under spinal anaesthesia hypotension may be managed by norepinephrine in preference to phenylephrine due a perception of less bradycardia and fewer reductions in cardiac output.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>As the optimum prophylactic dose of norepinephrine is unclear, we aimed to investigate its dose\u2013response for preventing postspinal hypotension in caesarean delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>A randomised, double-blinded, dose-finding study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING<\/jats:title>\n                    <jats:p>Jiaxing University affiliated Women and Children Hospital, Jiaxing, China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS<\/jats:title>\n                    <jats:p>\n                      Ninety-nine patients undergoing elective caesarean delivery from 1 February to 5 August: excluding patients with ASA III or above, preeclampsia or hypertension, pre-existing or gestational diabetes, BMI more than 35\u200akg\u200am\n                      <jats:sup>\u22122<\/jats:sup>\n                      , height less than 150\u200acm or with more than 175\u200acm, or with contraindications to local anaesthesia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS<\/jats:title>\n                    <jats:p>\n                      Patients received 0, 0.04, 0.05, 0.06 or 0.07\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      preventive norepinephrine infusions immediately after intrathecal injection of 10\u200amg bupivacaine with 5\u200a\u03bcg sufentanil.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOME MEASURES<\/jats:title>\n                    <jats:p>\n                      The norepinephrine (Median effective dose) or (95% effective dose) ED\n                      <jats:sub>50<\/jats:sub>\n                      and ED\n                      <jats:sub>95<\/jats:sub>\n                      , which were estimated using Probit analysis to compare haemodynamic changes associated with the different doses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The incidence of hypotension was 70, 47.4, 40, 20 and 15% in the 0, 0.04, 0.05, 0.06 and 0.07\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      groups, respectively. The ED\n                      <jats:sub>50<\/jats:sub>\n                      , ED\n                      <jats:sub>80<\/jats:sub>\n                      and ED\n                      <jats:sub>95<\/jats:sub>\n                      values were 0.029 (95% CI 0.008 to 0.042\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), 0.068 (95% CI 0.055 to 0.099\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) and 0.105\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      (95% CI 0.082 to 0.172\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      ), respectively. Apgar scores or umbilical arterial pH were similar among groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      The ED\n                      <jats:sub>50<\/jats:sub>\n                      , ED\n                      <jats:sub>80<\/jats:sub>\n                      and ED\n                      <jats:sub>95<\/jats:sub>\n                      were 0.029, 0.068 and 0.105\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      respectively. A 0.07\u200a\u03bcg\u200akg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u200amin\n                      <jats:sup>\u22121<\/jats:sup>\n                      norepinephrine infusion may be optimum for preventing postspinal hypotension after intrathecal injection of 10\u200amg bupivacaine combined with 5\u200a\u03bcg sufentanil.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Registry (identifier: ChiCTR-TRC-1800014614).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/eja.0000000000001152","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T14:13:56Z","timestamp":1579875236000},"page":"309-315","source":"Crossref","is-referenced-by-count":47,"title":["Norepinephrine for the prevention of spinal-induced hypotension during caesarean delivery under combined spinal\u2013epidural anaesthesia"],"prefix":"10.1097","volume":"37","author":[{"given":"Changna","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijoa.2014.11.002","article-title":"Anesthetic technique for cesarean delivery and neonatal acid\u2013base status: a retrospective database analysis","volume":"24","author":"Strouch","year":"2015","journal-title":"Int J Obstet Anesth"},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1399-6576.2010.02239.x","article-title":"Definitions of hypotension after spinal anaesthesia for caesarean section: literature search and application to parturients","volume":"54","author":"Klohr","year":"2010","journal-title":"Acta Anaesth Scand"},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1213\/ANE.0000000000001905","article-title":"Prophylactic phenylephrine infusions to reduce severe spinal anesthesia hypotension during cesarean delivery in a resource-constrained environment","volume":"125","author":"Bishop","year":"2017","journal-title":"Anesth Analg"},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ACO.0000000000000453","article-title":"The use of vasopressors during spinal anaesthesia for caesarean section","volume":"30","author":"Ngan Kee","year":"2017","journal-title":"Curr Opin Anaesthesiol"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1213\/ANE.0b013e3181e1db21","article-title":"A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery","volume":"111","author":"Allen","year":"2010","journal-title":"Anesth Analg"},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1213\/ANE.0000000000001846","article-title":"Norepinephrine intermittent intravenous boluses to prevent hypotension during spinal anesthesia for cesarean delivery: a sequential allocation dose-finding study","volume":"125","author":"Onwochei","year":"2017","journal-title":"Anesth Analg"},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10877-016-9883-z","article-title":"Performance of a closed-loop feedback computer-controlled infusion system for maintaining blood pressure during spinal anaesthesia for caesarean section: a randomized controlled comparison of norepinephrine versus phenylephrine","volume":"31","author":"Ngan Kee","year":"2017","journal-title":"J Clin Monit Comput"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0000000000001880","article-title":"A random-allocation graded dose-response study of norepinephrine and phenylephrine for treating hypotension during spinal anesthesia for cesarean delivery","volume":"127","author":"Ngan Kee","year":"2017","journal-title":"Anesthesiology"},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1213\/ANE.0000000000002243","article-title":"Prophylactic norepinephrine infusion for preventing hypotension during spinal anesthesia for cesarean delivery","volume":"126","author":"Ngan Kee","year":"2018","journal-title":"Anesth Analg"},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ALN.0000000000002483","article-title":"Norepinephrine infusion for preventing postspinal anesthesia hypotension during cesarean delivery: a randomized dose-finding trial","volume":"130","author":"Hasanin","year":"2019","journal-title":"Anesthesiology"},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1213\/ANE.0000000000004092","article-title":"Dose\u2013response study of 4 weight-based phenylephrine infusion regimens for preventing hypotension during cesarean delivery under combined spinal\u2013epidural anesthesia","volume":"130","author":"Xiao","year":"2019","journal-title":"Anesth Analg"},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/ALN.0000000000000601","article-title":"Randomized double-blinded comparison of norepinephrine and phenylephrine for maintenance of blood pressure during spinal anesthesia for cesarean delivery","volume":"122","author":"Ngan Kee","year":"2015","journal-title":"Anesthesiology"},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/anae.14114","article-title":"Management of hypotension with vasopressors at caesarean section under spinal anaesthesia \u2013 have we found the Holy Grail of obstetric anaesthesia?","volume":"73","author":"Campbell","year":"2018","journal-title":"Anaesthesia"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1213\/ANE.0b013e31826ac3db","article-title":"Phenylephrine infusion versus bolus regimens during cesarean delivery under spinal anesthesia: a double-blind randomized clinical trial to assess hemodynamic changes","volume":"115","author":"Doherty","year":"2012","journal-title":"Anesth Analg"},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhm.2394","article-title":"Safety of peripheral intravenous administration of vasoactive medication","volume":"10","author":"Cardenas-Garcia","year":"2015","journal-title":"J Hosp Med"},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/ACO.0000000000000190","article-title":"The role of cardiac output monitoring in obstetric anesthesia","volume":"28","author":"Langesaeter","year":"2015","journal-title":"Curr Opin Anaesthesiol"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000001152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T17:28:33Z","timestamp":1692034113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000001152"}},"subtitle":["Randomised, double-blind, dose-finding study"],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000001152","relation":{},"ISSN":["0265-0215","1365-2346"],"issn-type":[{"value":"0265-0215","type":"print"},{"value":"1365-2346","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}